$ESGH
ESG Inc. Stock $esgh

$esgh Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000152013824000207 Filed on May 15, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q1
Revenue	$2.378M		$0.00
YoY Change
Cost Of Revenue	$2.469M		$1.465M
YoY Change	68.49%
Gross Profit	-$90.63K		$343.0K
YoY Change	-126.42%
Gross Profit Margin	-3.81%
Selling, General & Admin	$318.4K		$0.00
YoY Change			-100.0%
% of Gross Profit			0.0%
Research & Development	$131.1K		$130.2K
YoY Change	0.68%
% of Gross Profit			37.96%
Depreciation & Amortization	$453.3K		$65.00
YoY Change	697276.92%		0.0%
% of Gross Profit			0.02%
Operating Expenses	$449.4K		$2.065K
YoY Change	21662.91%		-92.65%
Operating Profit	-$540.0K		-$2.065K
YoY Change	26051.91%		-92.65%
Interest Expense	-$149.5K		$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$245.5K		-$121.9K
YoY Change	101.4%
Pretax Income	-$785.5K		-$2.064K
YoY Change	37956.59%		-92.65%
Income Tax
% Of Pretax Income
Net Earnings	-$587.7K		-$2.064K
YoY Change	28372.24%		-92.65%
Net Earnings / Revenue	-24.71%
Basic Earnings Per Share	-$0.03		$0.00
Diluted Earnings Per Share	-$0.03		$0.00
COMMON SHARES
Basic Shares Outstanding	25.90M shares	15.47M shares	15.47M shares
Diluted Shares Outstanding	25.90M shares		25.90M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments			$70.00K
YoY Change
Cash & Equivalents	$833.1K	$342.3K	$14.35K
Short-Term Investments			$60.00K
Other Short-Term Assets
YoY Change
Inventory	$718.2K	$1.651M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$2.149M	$2.239M	$74.35K
YoY Change	2790.04%	2671.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.94M	$18.69M	$899.00
YoY Change	1995582.09%	1939212.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$23.19M	$24.03M	$899.00
YoY Change	2579328.48%	2493126.45%
TOTAL ASSETS
Total Short-Term Assets	$2.149M	$2.239M	$74.35K
Total Long-Term Assets	$23.19M	$24.03M	$899.00
Total Assets	$25.34M	$26.27M	$75.25K
YoY Change	33572.77%	32040.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.303M	$1.450M	$1.000K
YoY Change	130160.1%	26591.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.17M	$12.05M	$1.000K
YoY Change	1217295.4%	221706.35%
LONG-TERM LIABILITIES
Long-Term Debt			$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.366M	$1.423M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.17M	$12.05M	$1.000K
Total Long-Term Liabilities	$1.366M	$1.423M	$0.00
Total Liabilities	$13.54M	$13.48M	$1.000K
YoY Change	1353880.5%	247895.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.812M	-$1.225M	-$65.92K
YoY Change	2649.51%	1818.08%
Common Stock	$25.90K	$25.90K	$15.47K
YoY Change	67.45%	67.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.776M	$9.523M	$74.25K
YoY Change
Total Liabilities & Shareholders Equity	$25.34M	$26.27M	$75.25K
YoY Change	33572.77%	32040.99%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$587.7K	-$2.064K
YoY Change	28372.24%	-92.65%
Depreciation, Depletion And Amortization	$453.3K	$65.00
YoY Change	697276.92%	0.0%
Cash From Operating Activities	$94.97K	$0.00
YoY Change		-100.0%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid	$14.84M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$138.5K
YoY Change
NET CHANGE
Cash From Operating Activities	$94.97K	0.000
Cash From Investing Activities		0.000
Cash From Financing Activities	$138.5K
Net Change In Cash	$490.7K	0.000
YoY Change		-100.0%
FREE CASH FLOW
Cash From Operating Activities	$94.97K	$0.00
Capital Expenditures		$0.00
Free Cash Flow		$0.00
YoY Change		-100.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	ESGH	Payable To Related Party Current PayableToRelatedPartyCurrent		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Proceeds From Loans ProceedsFromLoans		usd
CY2024Q1	us-gaap	Payments For Loans PaymentsForLoans		usd
CY2023Q1	us-gaap	Payments For Loans PaymentsForLoans		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross		usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-56532
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	ESG INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1918342
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	523 School House Rd.
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Kennett Square
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19348
CY2024Q1	dei	City Area Code CityAreaCode	267
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	467-5871
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25899468	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	833089	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	342342	usd
CY2024Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	202665	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	79221	usd
CY2024Q1	us-gaap	Supplies Supplies	394723	usd
CY2023Q4	us-gaap	Supplies Supplies	166010	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	718213	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1651376	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	2148690	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2238949	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17941182	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18694969	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3016003	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3085906	usd
CY2024Q1	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	2190735	usd
CY2023Q4	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	2211980	usd
CY2024Q1	ESGH	Note Receivable Noncurrent NoteReceivableNoncurrent	41142	usd
CY2023Q4	ESGH	Note Receivable Noncurrent NoteReceivableNoncurrent	41848	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	23189062	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	24034703	usd
CY2024Q1	us-gaap	Assets Assets	25337752	usd
CY2023Q4	us-gaap	Assets Assets	26273652	usd
CY2024Q1	srt	Bank Loans BankLoans	7201019	usd
CY2023Q4	srt	Bank Loans BankLoans	6904228	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1302601	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1450405	usd
CY2023Q4	ESGH	Payable To Related Party Current PayableToRelatedPartyCurrent	30000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2377303	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2312772	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1293031	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1355552	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12173954	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12052957	usd
CY2024Q1	ESGH	Longterm Payable Noncurrent LongtermPayableNoncurrent	1365851	usd
CY2023Q4	ESGH	Longterm Payable Noncurrent LongtermPayableNoncurrent	1423116	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1365851	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1423116	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	2468914	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1465329	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-90633	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	342990	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	131088	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	130204	usd
CY2024Q1	us-gaap	Selling Expense SellingExpense	199	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	223	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	318177	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	273141	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	449404	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	403568	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-540037	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-60578	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-149487	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-149714	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-95964	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27844	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-245451	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-121870	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-785488	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-182448	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-785488	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-182448	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-197821	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-40100	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-587667	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-142348	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-159580	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	43059	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	54564	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-14723	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-747247	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-99289	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-252385	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-25377	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25899468	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25899468	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25899468	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25899468	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12797579	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-785488	usd
CY2024Q1	ESGH	Foreign Currency Translation Gain ForeignCurrencyTranslationGain	-214144	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11797947	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13567729	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-182448	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest	57782	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13443063	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-785488	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-182448	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	453295	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	471559	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	123444	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	112415	usd
CY2024Q1	ESGH	Increase Decrease In Advance To Suppliers IncreaseDecreaseInAdvanceToSuppliers	228713	usd
CY2023Q1	ESGH	Increase Decrease In Advance To Suppliers IncreaseDecreaseInAdvanceToSuppliers	-58452	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-933163	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-476941	usd
CY2024Q1	ESGH	Increase Decrease In Value Added Tax Receivable IncreaseDecreaseInValueAddedTaxReceivable	21245	usd
CY2023Q1	ESGH	Increase Decrease In Value Added Tax Receivable IncreaseDecreaseInValueAddedTaxReceivable	8212	usd
CY2024Q1	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-706	usd
CY2023Q1	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	250	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-147801	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-286874	usd
CY2024Q1	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	-30000	usd
CY2023Q1	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	30000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	64532	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	132908	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-62521	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-97625	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	94973	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	498460	usd
CY2024Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	138481	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	138481	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	257292	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-141083	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	490747	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	357377	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	342342	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	206621	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	833089	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	563998	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	150396	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	142453	usd
CY2023Q4	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	10432800	shares
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zf8A8VTDqvo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86A_zsoJfKK4Qh3">Use of estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting year. Significant items subject to such estimates and assumptions include allowance for doubtful accounts, advances to suppliers, valuation of inventories, useful lives of property, plant, and equipment and intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	us-gaap	Advances To Affiliate AdvancesToAffiliate	394723	usd
CY2023Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	166010	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	718213	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1651376	usd
CY2024Q1	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p id="xdx_841_eus-gaap--RevenueRecognitionDeferredRevenue_zMVS3KqoBZl6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_865_zZtRQX9TgrX2">Deferred income</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred income consists primarily of government grants. Government grants (sometimes referred to as subsidies, subventions, etc.) are as assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Government grants received relating to depreciable assets are recorded as deferred income and recognized in over the life of the related assets. The Company recorded income when receiving a grant which constitutes compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	131088	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	130204	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-197821	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-40100	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zDnGY7dFqDXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_860_zok9sKtn8rPj">Concentration of credit risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company maintains cash in accounts with state-owned banks within the PRC. Cash in state-owned banks less than $<span id="xdx_90D_eus-gaap--Cash_c20240331_pp0p0" title="Cash">69,241</span> (RMB<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_uRMB_c20240331_z2SbGPtePfbl" title="Cash">500,000</span>) is covered by insurance. Should any institution holding the Company’s cash become insolvent, or if the Company is unable to withdraw funds for any reason, the Company could lose the cash on deposit with that institution. The Company has not experienced any losses in such accounts and believes it is not exposed to any risks on its cash in these bank accounts. Cash denominated in RMB with a U.S. dollar equivalent of $<span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_c20240331_pp0p0" title="Cash equivalents">806,593</span> and $<span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_c20231231_pp0p0" title="Cash equivalents">317,947</span> as of March 31, 2024 and December 31, 2023, respectively, was held in accounts at financial institutions located in the PRC‚ which is not freely convertible into foreign currencies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">In 2023, the Company signed long-term contracts to sell mushroom to two distributors who accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--DistributorOneMember_pdd" title="Concentration of credit risk">78%</span> and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--DistributorTwoMember_pdd" title="Concentration of credit risk">22%</span> of total revenue for the three months ended March 31, 2024 comparing to <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--DistributorOneMember_pdd" title="Concentration of credit risk">16%</span> and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--DistributorTwoMember_pdd" title="Concentration of credit risk">12%</span> of total revenue for the three months ended March 31, 2023. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q1	us-gaap	Cash Cash	69241	usd
CY2024Q1	us-gaap	Cash Cash	500000
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	806593	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	317947	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-587667	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-142348	usd
CY2024Q1	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	1812478	usd
CY2023Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	1224811	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	833089	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	342342	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24466612	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24895726	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6525430	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6200757	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17941182	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18694969	usd
CY2024Q1	us-gaap	Depreciation Depreciation	436277	usd
CY2023Q1	us-gaap	Depreciation Depreciation	471559	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	118860	usd
CY2024Q1	us-gaap	Other Receivables OtherReceivables	83805	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	79221	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	202665	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	79221	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	585787	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1516634	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	88774	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	90326	usd
CY2024Q1	ESGH	Inventory Work In Process Growing Mushrooms InventoryWorkInProcessGrowingMushrooms	43652	usd
CY2023Q4	ESGH	Inventory Work In Process Growing Mushrooms InventoryWorkInProcessGrowingMushrooms	44416	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	718213	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1651376	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3285287	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3342733	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-269284	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-256827	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3016003	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3085906	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17017	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17464	usd
CY2024Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	7201019	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	6909229	usd
CY2024Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	34498	usd
CY2023Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	63867	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	140444	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	181950	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	14662	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	16131	usd
CY2024Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2187699	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2050824	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2377303	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2312772	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	72822	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	344686	usd
CY2024Q1	ESGH	Tax Break TaxBreak	15293	usd
CY2023Q1	ESGH	Tax Break TaxBreak	72384	usd
CY2024Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2024Q1	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	2190735	usd
CY2023Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	2211980	usd
CY2024Q1	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Rate NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationRate	1	pure
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2151383	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	14840028
CY2024Q1	ESGH	Monthly Payment MonthlyPayment	25612	usd
CY2024Q1	ESGH	Monthly Payment MonthlyPayment	176667
CY2024Q1	us-gaap	Deferred Income DeferredIncome	1293031	usd
CY2023Q4	us-gaap	Deferred Income DeferredIncome	1355552	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.04	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.04	pure
CY2024Q1	ESGH	Effect Of Income Tax Exemption On Certain Income EffectOfIncomeTaxExemptionOnCertainIncome	-0.02	pure
CY2023Q1	ESGH	Effect Of Income Tax Exemption On Certain Income EffectOfIncomeTaxExemptionOnCertainIncome	-0.24	pure
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.27	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.49	pure
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-173589	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-128384	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	173589	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	128384	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2704733	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2531144	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2704733	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2531144	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	65000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	65000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25899468	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25899468	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25899468	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25899468	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	ESGH	Number Of Common Stock Transferred NumberOfCommonStockTransferred	14000000	shares

Files In Submission

Name	View Source	Status
0001520138-24-000207-index-headers.html	Edgar Link	pending
0001520138-24-000207-index.html	Edgar Link	pending
0001520138-24-000207.txt	Edgar Link	pending
0001520138-24-000207-xbrl.zip	Edgar Link	pending
esgh-20240331.xsd	Edgar Link	pending
esgh-20240331_10q.htm	Edgar Link	pending
esgh-20240331_ex31z1.htm	Edgar Link	pending
esgh-20240331_ex32z1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
esgh-20240331_def.xml	Edgar Link	unprocessable
esgh-20240331_lab.xml	Edgar Link	unprocessable
esgh-20240331_pre.xml	Edgar Link	unprocessable
esgh-20240331_10q_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
esgh-20240331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESGH
ESG Inc. Stock $esgh

2024 Q1 Form 10-Q Financial Statement

#000152013824000207 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESGH ESG Inc. Stock $esgh

2024 Q1 Form 10-Q Financial Statement

#000152013824000207 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESGH
ESG Inc. Stock $esgh